The pharmaceutical company could compensate victims up to $25 million. For the first time, AstraZeneca admitted in court that its Covid-19 vaccine may have side effects, particularly blood clots.
The company has been called to account following numerous lawsuits filed by people who received the vaccine and families of alleged victims.
In the ongoing trial papers, AstraZeneca acknowledged that, “for reasons that are still unknown,” the vaccine can cause thrombosis with thrombocytopenic syndrome (TTS), a condition characterized by blood clots and a low platelet count. The company stresses that TTS is a very rare event and that the underlying causal mechanism is not yet fully understood.
According to some of the lawyers following the cases, if it loses in court, AstraZeneca could be forced to compensate the victims up to 25 million dollars.
In Italy, the most emblematic case is that of Camilla Canepa, the 18-year-old who died in June 2021 after receiving the AstraZeneca vaccine. The Genoa Prosecutor's Office recently established that the young woman "had a high probability of survival" and has placed five doctors from the emergency room in Lavagna under investigation, where Camilla had gone on the evening of June 3 with symptoms of an adverse reaction to the vaccine. The girl was struck down by Vitt, a very rare cerebral thrombosis associated with the adenoviral vaccine.
AstraZeneca's admission has sparked a new controversy over the vaccine's side effects, which had already been the subject of heated debate since 2021, when the first Covid-19 vaccines were distributed.
AstraZeneca disputes claims of a “defect” in the product and reiterates the importance of vaccination in the fight against the pandemic. The company stresses that the benefits of the vaccine far outweigh the risks and that TTS is an extremely rare event.
The AstraZeneca case highlights the need for clear and transparent communication from pharmaceutical companies about the side effects of their products. Citizens have the right to be fully and impartially informed about the risks and benefits of vaccines, so they can make informed decisions about their health.
Article published on 30 April 2024 - 13:06